A close association was observed between a higher CRP level (CRP≥5.0 mg/L) and clinical stage (χ2 trend test: P = 0.005), clinical nodal status (χ2 trend test: P = 0.003), and tumor differentiation (χ2trend test: P = 0.014) (Table 2). This evidence concerns the gene CRP and neoplasm.